Gsk Share Discussion Threads

[spyder] 26/7/2022 16:48

We will know soon enough TM.

[tradermichael] 26/7/2022 15:31

After all this, Q2 results had better look good !!!!

[tradermichael] 26/7/2022 13:48

2022 Second quarter
27 July 2022
We will announce our second quarter 2022 results at 07:00 BST, 02:00 EDT on Wednesday 27 July.

Following the announcement there will be a webcast hosted by Emma Walmsley, CEO, and other members of the GSK Leadership Team at 12:00 BST, 07:00 EDT.

[tradermichael] 25/7/2022 09:44

These calculated costs are also useful in re-calculating individual 'break even' values for the two individual shares, GSK and HLN.

[suetballs] 25/7/2022 09:44

Yep - I couldn't find it either but emailed the company who replied very promptly.
Suet

[tradermichael] 25/7/2022 09:14

Yes! 18.16% - Thanks suetballs, very useful.
It looks like the helpsheet originated from GSK, which I couldn't find!

[spyder] 25/7/2022 09:10

Well done TM, you were very close!!

[tradermichael] 25/7/2022 08:42

For capital gains purposes, I've been determining the book value for the Haleon shares that were issued to me as a reult of the demerger.

It looks like 19% of the cost of acquiring my original total Glaxosmithkline shares.

Anyone agree/disagree?

[anhar] 22/7/2022 11:18

Yes you're correct TM in quoting that info from GSK. My comments forgot the consolidation :~( though it comes to the same thing in 2022, 27p for H1 and 22p for H2 on GSK on the pre-consol holding or the equivalent figures they state in that quote as adjusted for the consol, for an investor holding since old GSK and who had already received the Q1 divi of 14p.

Overall then, in cash terms an investor (like me) who held before Q1 22 can expect I think for 22:

14p Q1 (per old GSK share) + 16.25p Q2 + 27.5p for Qs3 and 4 (all three per new GSK share) making 57.75p. This is the consol-adjusted figure of the previously expected 49p and amounts to the same as if there had been no consol.

My HLN expected 3p remains correct as is the effective total for 22 and cut in divis for an investor continuing to hold both new shares.

Think I've got it right this time!

[tradermichael] 22/7/2022 10:51

GSK has previously stated that it expected to declare a 27p per share dividend for the first half of 2022, a 22p per share dividend for the second half of 2022 and a 45p per share dividend for 2023, but that these targeted dividends per share would increase in step with the GSK Share Consolidation to maintain the same aggregate dividend pay-out in absolute Pound Sterling terms.

Accordingly, using the consolidation ratio, GSK’s expected dividend for the second quarter of 2022 converts to 16.25p per new ordinary share (taking into account the dividend of 14p per share paid for the first quarter of 2022), the expected dividend for the second half of 2022 converts to 27.5p per new ordinary share and the expected dividend for 2023 converts to 56.25p per new ordinary share.

GSK expects to publish its results for the second quarter of 2022 on Wednesday 27 July 2022 which will confirm the dividend to be declared for that quarter.

[anhar] 22/7/2022 00:30

nico9: How are Dividends affected. Do we get same 80p ps for GSK but for less shares we own? Do we get an HLN Divi at all? If so, do we know how much? TIA

There's some inaccurate responses to this query. The actual figures are in the circular dated 01 June 2022, in summary:

New GSK expects to pay 27p for the first half of 2022 and 22p for the second half, making 49p in total. These payments apply to the number of shares held post-consolidation.

HLN expects no divi for the first half of 22 as this is included in GSK's first half above, and predicts around 3p for the second half.

Thus in total for those investors retaining both new shares, the payout is anticipated at about 52p for 22, a 35% cut against the 80p paid last year by old GSK.

Divis are never guaranteed so these figures could change.

[criticalthinker1] 21/7/2022 17:08

£34m purchase of Haleon after close!
I expect another climb tomorrow.
30% undervalued imo.
How long until a TR1?
GSK I'm sure will announce further pipelines soon...one of which I've seen one company tidying up research updates...

[jonjoneil] 21/7/2022 16:17

good move I think. When Emma sings, the shares usually take a temporary drop

[mj19] 21/7/2022 16:12

Waiting on trading update before I buy more

[tradermichael] 21/7/2022 14:08

My AJ Bell accounts completed consolidation on Tuesday

[chocaholic] 21/7/2022 13:58

Swissquote is still showing my full original GSK holding but gives a message of Server Error if I try to trade. Haleon seems to be fine and tradeable. Has everyone already had the consolidation carried out on their GSK holding? I thought it should have been done at 0800 on the 19th.

[abdullla] 21/7/2022 08:33

27 July 2022

[mj19] 21/7/2022 08:26

Anyone know when the next trading update is?

[pierre oreilly] 21/7/2022 08:19

Soz, 25% yield increase.

[pierre oreilly] 21/7/2022 08:18

The divi is explained in the latest rns.Basically, they are paying the same cash amount as pre split. So we get the same divi cash amount on 20% fewer shares. That effectively means a 20% yield increase.Very surprising.

[mj19] 21/7/2022 08:08

21 Jul 2022 07:29amGSK : CITIGROUP RESUMES COVERAGE WITH NEUTRAL RATING; TARGET PRICE 1975PThis news story contains no content21 Jul 2022 06:01amGSK : BERENBERG RAISES TARGET PRICE TO 1950P FROM 1850PThis news story contains no content20 Jul 2022 10:04amGSK : UBS CUTS TARGET PRICE TO 1850P FROM 1876PThis news story contains no content